Cor Vasa 2009, 51(4):279-281 | DOI: 10.33678/cor.2009.068
Treatment of severe pulmonary hypertension with sildenafil in a heart transplant candidate for advanced heart failure
- Klinika kardiologie, Institut klinické a experimentální medicíny, Praha, Česká republika
In patients with end-stage heart failure, severe pulmonary hypertension is a contraindication to heart transplantation because of the risk for right ventricular failure in the early postoperative period, when the ventricle becomes suddenly exposed to high pressure in the pulmonary circuit. We present the case report of a patient with advanced heart failure and severe pulmonary hypertension, whose -hemodynamic parameters were favorably modulated with sildenafil therapy.
Keywords: Pulmonary hypertension; Chronic heart failure; Heart transplantation; Sildenafil
Published: April 1, 2009 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
Cihlová M, Al-Hiti H, Melenovský V, Málek I, Kautzner J. Treatment of severe pulmonary hypertension with sildenafil in a heart transplant candidate for advanced heart failure. Cor Vasa. 2009;51(4):279-281. doi: 10.33678/cor.2009.068.
References
- Butler J, Chomsky DB, Wilson JR. Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol 1999;34:1802-6.
Go to original source... - Ghofrani HA, Pepke-Zaba J, Barbera JA, et al. Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:68S-72S. Go to original source...
Go to PubMed... - Chen JM, Levin HR, Michler RE, Prusmack CJ, Rose EA, Aaronson KD. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: Determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg 1997;114:627-34. Go to original source... Go to PubMed...
- Lewis GD, Shah R, Shahzad K, et al. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 2007;116:1555-62. Go to original source... Go to PubMed...
- Lewis GD, Lachmann J, Camuso J, et al. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 2007;115:59-66. Go to original source... Go to PubMed...
- Guazzi M, Tumminello G, Di Marco F, Fiorentini C, Guazzi MD. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol 2004;44: 2339-48. Go to original source... Go to PubMed...
- Lepore JJ, Maroo A, Bigatello LM, et al. Hemodynamic effect of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide. Chest 2005;127: 1647-53. Go to original source... Go to PubMed...
- Alaeddini J, Uber PA, Park MH, Scott RL, Ventura HO, Mehra MR. Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure. Am J Cardiol 2004;94:1475-7. Go to original source... Go to PubMed...
- Maruszewski M, Zakliczyński M, Przybylski R, Kucewicz-Czech E, Zembala M. Use of sildenafil in heart transplant recipiens with pulmonary hypertension may prevent right heart failure. Transplant Proc 2007;39:2850-2. Go to original source... Go to PubMed...
- Jabbour A, Keogh A, Hayward C, Macdonald P. Chronic sildenafil lowers transpulmonary gradient and improves cardiac output allowing successful heart transplantation. Eur J Heart Fail 2007;9:674-7. Go to original source... Go to PubMed...